Rothschild Asset Management Inc. lowered its position in shares of Agilent Technologies, Inc. (NYSE:A) by 18.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,652 shares of the medical research company’s stock after selling 1,930 shares during the period. Rothschild Asset Management Inc.’s holdings in Agilent Technologies were worth $555,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Jennison Associates LLC purchased a new position in Agilent Technologies in the 2nd quarter valued at approximately $212,000. Commerce Bank acquired a new stake in Agilent Technologies during the 2nd quarter worth $1,242,000. Delta Lloyd Asset Management N.V. acquired a new stake in Agilent Technologies during the 2nd quarter worth $2,026,000. Prudential Financial Inc. raised its stake in Agilent Technologies by 2.5% during the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock worth $27,134,000 after acquiring an additional 11,020 shares in the last quarter. Finally, Cipher Capital LP raised its stake in Agilent Technologies by 18.1% during the 2nd quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after acquiring an additional 13,703 shares in the last quarter.
In other news, CFO Didier Hirsch sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $64.00, for a total value of $1,280,000.00. Following the completion of the transaction, the chief financial officer now owns 183,002 shares of the company’s stock, valued at $11,712,128. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Boon Hwee Koh sold 4,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total transaction of $286,335.00. The disclosure for this sale can be found here. Insiders sold 107,709 shares of company stock worth $7,195,576 in the last ninety days.
Shares of Agilent Technologies, Inc. (NYSE:A) opened at $69.36 on Friday. The company has a market cap of $22,106.37, a PE ratio of 28.98, a P/E/G ratio of 2.07 and a beta of 1.27. Agilent Technologies, Inc. has a fifty-two week low of $42.92 and a fifty-two week high of $70.81. The company has a current ratio of 3.30, a quick ratio of 2.76 and a debt-to-equity ratio of 0.37.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The company had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the prior year, the firm earned $0.59 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. analysts forecast that Agilent Technologies, Inc. will post 2.58 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be issued a $0.149 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Friday, December 29th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is 25.24%.
A number of research analysts have commented on A shares. Deutsche Bank AG set a $75.00 price objective on shares of Agilent Technologies and gave the company a “buy” rating in a research note on Tuesday, November 21st. J P Morgan Chase & Co lifted their price objective on shares of Agilent Technologies to $75.00 and gave the company an “overweight” rating in a research note on Tuesday, November 21st. Barclays PLC lifted their price objective on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a research note on Tuesday, November 21st. Cowen Inc reaffirmed a “hold” rating and issued a $70.00 target price on shares of Agilent Technologies in a report on Wednesday. Finally, Robert W. Baird reaffirmed a “buy” rating and issued a $72.00 target price on shares of Agilent Technologies in a report on Friday. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $68.34.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.